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Abstract—Bone-anchored limb prostheses allow for the
direct transfer of external loads from the prosthesis to the
skeleton, eliminating the need for a socket and the associated
problems of poor ﬁt, discomfort, and limited range of
movement. A percutaneous implant system for direct skeletal
attachment of an external limb must provide a long-term,
mechanically stable interface to the bone, along with an
infection barrier to the external environment. In addition, the
mechanical integrity of the implant system and bone must be
preserved despite constant stresses induced by the limb
prosthesis. Three different percutaneous implant systems for
direct skeletal attachment of external limb prostheses are
currently clinically available and a few others are under
investigation in human subjects. These systems employ
different strategies and have undergone design changes with
a view to fulﬁlling the aforementioned requirements. This
review summarises such strategies and design changes,
providing an overview of the biomechanical characteristics
of current percutaneous implant systems for direct skeletal
attachment of amputation limb prostheses.
Keywords—Bone-anchored prostheses, Osseointegration, Di-
rect skeletal attachment.
ABBREVIATIONS
AEAHBMAlameda East Animal Hospital BioMed-
trix
ILP Integral leg prosthesis
ITAP Intraosseous transcutaneous amputation
prosthesis
OPL Osseointegrated prosthetic limb
OPRA Osseointegration prostheses for the reha-
bilitation of amputees
POP Percutaneous osseointegrated prosthesis
UHMWPEUltra-high-molecular-weight polyethylene
INTRODUCTION
Conventionally, a limb prosthesis is attached to the
stump of an amputee by the use of a socket, which
suspends the prosthesis to the stump by compressing
over soft tissues. However, the socket-stump interface
often causes such complications as poor ﬁt, discom-
fort, skin problems, sweating, and pressure
sores.19,29,52,58,70 An alternative way to attach limb
prostheses to the human body is to bypass the soft-
tissue in the stump for direct load transfer to the
skeletal system. In this concept, a percutaneous im-
plant system is surgically implanted with its proximal
end directly into bone tissue in the stump. The distal
end of the implant system extends percutaneously from
the residual limb and allows for the attachment of an
external prosthesis. This eliminates the need for a
compression socket and eliminates well-known socket-
associated problems. Additional beneﬁts of direct
skeletal attachment of limb prostheses reported in the
literature include improved range of motion,31,74
walking ability,24,32 sitting comfort,31 reduced energy
expenditure,76 and improved awareness via osseoper-
ception.33,42 In the 1960s and 1970s, several attempts
were made on animals to achieve direct skeletal
attachment of limb prostheses. In most of these
experiments, intramedullary rods of stainless steel or
cobalt-chrome-molybdenum alloy were used,35,36
however, no long-term successful results were
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reported. Sandblasted surface treatment, porous cera-
mic coatings,35,36 composite materials of glass ﬁbres or
carbon ﬁbres in plastic matrices,36 and alternative de-
signs with supra-cortical-, or supra-periosteal attach-
ment,36–38 to the bone have also been tried, without
satisfactory outcomes. In 1977, Mooney reported on
unsuccessful attempts on three human transhumeral
amputees with intramedullary stainless steel implants
ﬁxed with bone cement.59 Most of the failures have
been attributed to infection at the skin penetration site
and loosening at the bone-implant interface.
In the early 1960s, P.-I. Bra˚nemark discovered the
ability of bone tissue to closely adhere and form a
strong mechanical bond to titanium. He introduced the
term osseointegration as direct anchorage to bone tis-
sue to describe this close contact.16 Bra˚nemark pio-
neered the use of titanium as implant material for
dental prostheses in the treatment of edentulous
patients, with positive clinical results.16 From these
ﬁndings, the concept was later extended to the ortho-
paedic ﬁeld when an implant system for direct skeletal
attachment of limb prostheses was developed and im-
planted in a bilateral transfemoral amputee in Sweden
for the ﬁrst time in 1990.21 The system was further
developed to accommodate other amputation levels.
Early implants were custom designed until 1999, when
the Swedish system was introduced to the market un-
der the name OPRA (Osseointegrated Prostheses for
the Rehabilitation of Amputees, Integrum AB, Mo¨ln-
dal, Sweden). The OPRA implant system is currently
available in 12 countries. Following the successful re-
sults in Sweden, another implant system was inde-
pendently developed in Germany under the name of
ILP (Integral Leg Prosthesis, Orthodynamics GMbH,
Lu¨beck, Germany). In 1999, the ﬁrst patient was
treated with the ILP implant system,10 which is now in
clinical use in Germany, the Netherlands, and Aus-
tralia. Another system, based on the ILP design, was
recently developed in Australia under the name of OPL
(Osseointegrated Prosthetic Limb, Permedica s.p.a.,
Milan, Italy). This system is also clinically available in
The Netherlands. To date OPRA, ILP, and OPL are
the only commercially available systems for direct
skeletal attachment of external limb prostheses. How-
ever, a number of newer systems are under develop-
ment, four of which have reached the stage of clinical
experiments in humans. These are the ITAP71 (In-
traosseous Transcutaneous Amputation Prosthesis,
Stanmore Implants Worldwide, Watford, United
Kingdom) developed in the United Kingdom, the
Keep Walking Advanced27 (Tequir S.L., Valencia,
Spain) developed in Spain, and two systems developed
in the United States: POP20 (Percutaneous Osseointe-
grated Prosthesis, DJO Global, Austin, USA) and
COMPRESS57 (Zimmer Biomet, Warsaw, USA). In
addition to these systems, implantation of a custom-
made implant for attachment of an external prostheses
in a transfemoral amputee has been reported in a single
case study in the USA.39 A number of other systems
have been tested in animal studies, but only the
AEAHBM (Alameda East Animal Hospital BioMed-
trix, Boonton, USA) developed in the USA, has shown
successful outcome for a load-bearing prosthetic limb
for more than one year.18
Previous reviews have focused on clinical78 and
functional outcomes,54 as well as the design features of
the implant systems.67 The present review aims to
characterise the biomechanical interfaces between the
implant and biological tissue, and between individual
components within each implant system. In this article,
the term ‘implant system’ refers to implanted and
percutaneous components, including external safety
devices, to which an external prosthesis can be at-
tached.
METHODS
A systematic literature review was performed using
the three databases: Scopus, Web of Science, and
PubMed. Article title, key words, and abstracts were
searched using the following search condition:
(osseointegrat* OR ‘‘skeletal attachment’’ OR
bone?anchored) AND (limb OR prosthes*) AND
(amput*) AND (implant*). The inclusion criteria for
the articles required them to contain a description of
an implant system that allows for direct skeletal
attachment of a load-bearing artiﬁcial limb. Load-
bearing limbs were deﬁned as upper or lower legs and
arms. Journal articles published prior to 1 April 2017
were considered. Conference proceedings, book chap-
ters, editorial letters, non-English, and non-Spanish
articles were excluded. The screening procedure is
presented in detail in Fig. 1. The ﬁltered search yielded
152 unique and relevant articles in total. The criteria
for inclusion was deﬁned as implant systems that (1)
allow for direct skeletal attachment of a load-bearing
artiﬁcial limb and (2) have been evaluated in human or
animal models of a load-bearing artiﬁcial limb with
successful function for at least 1 year. We identiﬁed
eight relevant implant systems that fulﬁlled these cri-
teria. In addition, a patent search in Derwent Innova-
tions Index and Espacenet was performed to obtain
further information about these implant systems. Only
patents describing the components of the previously
identiﬁed implant systems were considered. The peer-
reviewed research articles and patents were studied to
determine the characteristics of each of the implant
systems presented here.
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RESULTS
The eight identiﬁed implant systems are shown in
Figs. 2, 3, 4, 5, and 6 and described brieﬂy in this
section. Comparisons between the systems are pre-
sented in Tables 1 and 2.
OPRA
In 1998, the Swedish implant system, surgical tech-
nique, and postoperative rehabilitation protocol was
standardized for transfemoral amputees by the intro-
duction of the OPRA treatment protocol. Similar
standardisation has also been done for transhumeral
and thumb/ﬁnger amputations. Apart from the stan-
dardised implant versions, custom-made implants are
available for the aforementioned levels, as well as for
transtibial and transradial amputations. The OPRA
implant system mainly consists of three components:
(1) an externally threaded, cylinder-like, fully im-
planted component known as a ‘‘ﬁxture’’, where
osseointegration takes place; (2) a percutaneous com-
ponent called ‘‘abutment’’, which is press-ﬁt into the
distal end of the ﬁxture and to which the limb pros-
thesis is attached; and (3) an ‘‘abutment screw’’, which
extends through the hollow centre of the abutment to
clamp the abutment and the ﬁxture together by the
proximal thread engagement to the ﬁxture and the
abutment screw head on the distal end of the abutment
(Fig. 2a). Loads are transferred from the limb pros-
thesis to the abutment, then from the abutment to the
ﬁxture, and ﬁnally from the ﬁxture to the bone.
Implantation is normally done in two separate surg-
eries, but it can also be done in a single surgery on
FIGURE 1. Schematic view of the methodology used for the literature review and the search results. From the filtered article
search, the number of articles per implant system was determined according to the following criterion. In order to be counted as an
article for a particular implant system, the article had to describe the mechanical properties of the implant system or report results
from implantation of the implant system for direct skeletal attachment of a load-bearing artificial limb.
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patients who have acceptable bone quality and com-
pliance.56 Since its introduction, the OPRA implant
system has undergone several design changes. The
material has been changed from commercially pure
titanium to the stronger medical grade titanium alloy
Ti6Al4 V. A surface treatment of the exterior of the
ﬁxture called BioHelixTM (Fig. 2b) was added to in-
duce a nanoporous structure for improved osseointe-
gration.15 In addition to the design changes, the
surgical technique for lower limb amputations was
modiﬁed to implant the ﬁxture 20 mm countersunk
into the bone to address the problem of distal bone
resorption, which was sometimes observed when the
ﬁxture was placed ﬂush with the distal bone end,60,72,75
and to reduce the risk of infection in the bone-ﬁxture
interface.73 Because a ﬁxture failure requires a major
surgical intervention, the system was designed to en-
sure that the abutment and abutment screw fracture
before the ﬁxture, or the bone, should the system be
exposed to excessive loads, as these components are
more easily replaced than the ﬁxture. Additionally, the
lower limb systems and the transhumeral systems are
protected by a safety device that is attached between
the distal end of the abutment and the limb prosthesis.
The safety device automatically releases the connection
with the external prostheses if exposed to excessive
loads, thus protecting the implant system from expo-
sure to fracture inducing forces. In the studied litera-
ture, fatigue failure of ﬁxtures has been reported in a
transfemoral64 and a transradial patient,63 both using
an early design of the implant system. Mechanical
complications leading to revision of the abutment or
the abutment screw have also been reported,14,55 but
no measurement of the mechanical failure rate has
been published.
The OPRA implant system has been recently en-
hanced at the transhumeral level to allow bidirectional
communication with implanted neuromuscular inter-
FIGURE 2. (a) Schematic image of OPRA implant system in an amputated limb; (b) OPRA Fixture; the exterior surface in the dark
grey region is treated to enhance osseointegration. The lower image shows a close-up of the laser-induced micro structure from
the surface treatment; (c) Schematic image of the ILP implant system: (1) Porous coated portion of the intramedullary component
of the implant system, (2) inner lining, (3) Morse taper, (4) dual cone adapter, (5) knee connecting adapter. The red line indicates the
stoma channel; (d) Close-up of the spongiosa metal surface to enhance osseointegration and ingrowth; (e) ILP implant system
assembled; (f) Exploded view of ILP implant system assembly consisting of: (1) intramedullary implant, (2) temporary cover screw,
(3) dual cone adapter, (4) safety screw, (5) sleeve, (6) rotating disc (until prosthetist has made final adjustments), (7) final propeller
screw, (8) provisional screw; (g) OPL type-B implant system. Images A and B are published with courtesy of Integrum AB. Images
C, D, E and F are reprinted from Journal of Rehabilitation Research & Development.49 Image G is reprinted from Unfallchirurg6 with
permission from Springer.
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faces for the closed-loop control of arm prosthesis.61 In
current clinical trials, this novel osseointegrated inter-
face has, for the ﬁrst time, allowed the connection of
an arm prosthesis to the patient’s bone, nerves, and
muscles. This is currently the only neuroprosthetic
system that enables patients to operate a prosthetic
arm in daily life receiving sensory feedback via direct
nerve stimulation.62
ILP
The ILP implant system was designed for trans-
femoral amputees, but tibial and humeral implantation
has also been reported.10,11,40 The implant has a cast
stem of cobalt-chrome-molybdenum alloy and the
implant stem is 140–180 mm long and slightly curved
to prevent rotation in the intramedullary cavity and to
ﬁt to the normal curvature of the femur. Since its
introduction, the system has gone through several de-
sign changes. Both the intramedullary part of the im-
plant and the subdermal part was initially covered with
a 1.5 mm thick macroporous surface known as
‘‘spongiosa metal’’, consisting of tripod-like structures
(Fig. 2d).1,23 The implant also had a bone-stabilising
bracket, which wrapped around the cortical bone dis-
tally (Figs. 3a and 3b). As the bracket and the
macroporous surface towards the soft tissue were
found to cause complications, they were removed in
design versions 2 and 3, respectively (Figs. 3b and
3c).3,49 The latter design was introduced in Germany
200949 and subsequently in the Netherlands in
200953,77 and in Australia in 2010.3 Mechanical failures
of the intramedullary implant have been reported in all
three countries.5,23,49
OPL
The OPL was introduced in Australia in 20136 and
in the Netherlands in 2015.23 The system is used for
FIGURE 3. Design changes over time for the ILP implant. (a)
First ILP implant design. The material is medical-grade cobalt-
chrome alloy. The implant has a rough surface on both the
intramedullary region and the subdermal region. A bone-sta-
bilising bracket for improved fatigue properties; (b) Second
implant design. Rough surface on distal post and bracket
removed. Bracket, distal portion of implant and connector
reduced in size; (c) Third implant design. Bracket removed.
Revised connection to implant to a dual cone connection.
Reprinted from Journal of Rehabilitation Research & Devel-
opment.49
FIGURE 4. Examples of available OPL implants. (a) OPL type A with distal niobium polished extramedullary head; (b) OPL type B
with an intramedullary distal head; (c–e) Custom-made implants with macroporous 3D mesh coating for accelerated osseointe-
gration. Reprinted from Unfallchirurg.23
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transfemoral or transtibial amputation levels. Stan-
dardised implants are used for transfemoral amputees
with sufﬁcient stump length (‡ 160 mm), while cus-
tom-made implants are available for transtibial am-
putees and transfemoral amputees with very short
stumps (Fig. 4).23 This implant system has two stan-
dard designs: OPL type A, with an extramedullary
head (Fig. 4a), and OPL type B, with a ﬂared in-
tramedullary head for distal transfemoral amputa-
tions23 (Fig. 4b).
The changes from the ILP-3 to the OPL implant
design include material change to Ti6Al4 V, the
introduction of 1 mm high sharp longitudinal splines
proximally, and change from the macroporous
‘‘spongiosa metal’’ surface to a plasma-sprayed rough
titanium coating distally where osseointegration is
desired.2,4,6
POP
The POP system was developed in Salt Lake City,
USA. The system is currently being evaluated in an
early feasibility study in 10 transfemoral amputee
subjects.13,20,68 It is a modular system, implanted in
two separate surgeries. No further details have been
published regarding the design or the surgical protocol.
The human trial was preceded by animal studies of
load-bearing limb prostheses in sheep.41,43–46,69 How-
ever, the implant system used in the animal trials is
considerably different from the human system design.
The implant system in the animal trial consists of a
single component made of Ti6Al4 V (Fig. 5a). The
intramedullary part is divided into three regions: a
smooth region proximally, a ribbed region in the
middle, and a porous coated region distally. The por-
ous coating is combined with a collar shape to inter-
face against the distal end of the bone.
FIGURE 5. (a) Single-component POP implant used in sheep studies: (1) tapered smooth region, (2) fluted region, (3) porous
coated region, (4) porous coated subdermal barrier, (5) Morse taper for connection to exo-prosthesis; (b) POP implant system
assembly for humans: (1) implant stem, (2) stoma shield, (3) percutaneous post, (4) assembly bolt, (5) adapter, (6) adapter bolt; (c)
Schematic view of the ITAP implant; (d) Radiograph of ITAP implant in a transhumeral amputee; (e) ITAP implant used in dog
number 3 of the clinical study on dogs. Image A is reprinted from Clinical Orthopaedics and Related Research,47 with permission
from Springer. Image B is reprinted from US Patent 9,433,505.12 Images C and D are reprinted from Journal of Hand Surgery50 with
permission from Elsevier. Image E is reprinted from Veterinary Surgery22 with permission from John Wiley and Sons.
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ITAP
The ITAP implant system is under development in
the United Kingdom. A pre-CE mark clinical study for
transfemoral amputees71 has been started, but no re-
sults have yet been published. The published results of
the ITAP system include a case study from a two-year
follow-up of a transhumeral amputee,50 and a clinical
and functional outcome report from implantation of
custom made implant systems in four dogs.22 The
ITAP is a single-component system implanted in a
single surgery. Similar to the other implant systems,
with the exception of the ILP, the implant is made of
the titanium alloy Ti6Al4 V. The proximal region of
the intramedullary part of the ITAP has longitudinal
FIGURE 6. (a) Compress percutaneous device radiograph; (b) Schematic diagram of the Compress endoprosthetic implant,
demonstrating Belleville washers stacked over a traction bar housed within the endoprosthetic taper at the bone-prosthetic
interface; (c) Schematic view of the keep walking advanced implant system: (1) intramedullary rod, (2) spacer, (3) intermediate
device, (4) locking screw, (5) upper connecting piece, (6) lower connecting piece; (d) AEAHBM implant original design; yellow lines
represent the patient’s tibial shaft: (1) Tapered threaded stem of Ti6Al4 V, (2) base of porous tantalum sleeve, (3) Morse taper fitting
for external prosthesis; (e) AEAHBM implant modified design: (1) Intramedullary stem of Ti6Al4 V with longitudinal splines, (2)
porous tantalum sleeve, (3) external region of Ti6Al4 V implant. Image A has been adapted from Unfallchirurg57 with permission of
Springer. Image B has been adapted from International Orthopaedics51 with permission of Springer. Image C is published from
Rehabilitacio´n27 with permission of the Publisher. Images D and E are reprinted from Veterinary Surgery18 with permission from
John Wiley and Sons.
TABLE 1. Comparison of current percutaneous implant systems for direct skeletal attachment of external limb prostheses.
System Maturity of implant system Amputation levels
Number
of surgeries
Time between S1 and S2
(months)
Total recovery
time (months)
OPRA Clinically available Tibia, femur, humerus,
radius/ulna, thumb, finger
1 or 2 3–6 3–18a
ILP Clinically available Tibia, femur, humerus 2 1.5–2 2.5–4.58,10,49
OPL Clinically available Tibia, femur 1 or 2 1.5–2 4.58
ITAP Pre-CE mark clinical trial Femur, humerus 1 – –
POP FDA early feasibility study Femur 2 1.513 –
Compress Custom device Femur, humerus 1 or 2 3–457 –
Keep walking advanced Clinical trial Femur 2 327 –
AEAHBM Case study in dog – 1 – –
a12–18 months for transfemoral and transtibial amputations, 10–12 months for transhumeral amputations, 9 months for transradial ampu-
tations, and 3 months for thumb amputations.
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cutting ﬂutes (Fig. 5c) aimed to improve rotational
stability. The subdermal and distal regions of the in-
tramedullary part of the implant have a hydroxyap-
atite coating to promote soft tissue ingrowth and bone-
anchorage. Since there are no publications available
from the clinical study, it is unclear whether the bone
anchorage is obtained with or without bone cement.
Another design characteristic of the ITAP system is a
subdermal porous ﬂange towards the distal end of the
residual stump to serve as a platform for soft tissue
ingrowth and skin attachment to minimise the relative
movement at the percutaneous interface.22,50,66
COMPRESS
The COMPRESS system (Figs. 6a and 6b) was ﬁrst
developed as an endo-prosthetic system for oncologic
limb salvage reconstruction by Biomet Corporation
(now Zimmer Biomet, Warsaw, USA). The in-
tramedullary part of the implant is attached to the
bone by transverse pins in a bone-anchor plug. A
porous coated collar designed to promote osseointe-
gration is located at the distal interface of the ampu-
tated bone. To enhance osseointegration and to
prevent stress-shielding of the bone, the concept of
compliant pre-stress is utilised, exposing the bone-
collar interface to a compressive force. Under a FDA
custom device exception, a percutaneous version of
this system enabling attachment of an external limb
prosthesis has been developed and implanted in 10
transfemoral amputees and one transhumeral ampu-
tee. Both single-stage and two-stage surgeries have
been used for implantation of the system.57 Two cases
of periprosthetic fractures caused by falls have been
reported among the transfemoral subjects.57
Keep Walking Advanced
This system is under development in Valencia,
Spain. It is an extension of the Keep Walking system
for socket stabilization in transfemoral amputees. In
the Keep Walking system, an intramedullary titanium
rod is press-ﬁt into the femur to allow for osseointe-
gration.28 The distal end of the rod is connected to a
large subdermal component, which serves to transfer
the load from the femur and distribute it evenly to the
socket of the prosthesis to avoid discomfort and soft
tissue damage. In the Keep Walking Advanced system
(Fig. 6c), a percutaneous extension is added to the
subdermal implant in a second surgery. The extension
allows for skeletal attachment of an external prosthe-
sis, eliminating the need for the compression socket.
The Keep Walking Advanced system is currently being
evaluated in a clinical trial. A single case study of a 38-
year-old female transfemoral amputee who received
the system in 2013 has been reported,27 but no infor-
mation about functional outcome has been presented.
AEAHBM
The AEAHBM implant system developed in Den-
ver, Colorado was custom-made for a single surgery
implantation of a single-component system into both
pelvic limbs of a dog18 (Fig. 6d). One of the implants
had to be removed because of failed osseointegration
after 14 months, but a redesigned implant (Fig. 6e)
was implanted with successful results up to the time of
the report, 26 months after the initial surgery. The
original implant consisted of a threaded tapered in-
tramedullary stem consisting of Ti6Al4 V. The distal
end of the stem was covered by a porous tantalum
sleeve to allow for soft tissue integration while also
TABLE 2. Comparison of material and interface characteristics of current percutaneous implant systems for direct skeletal
attachment of external limb prostheses.
System Material
Interfaces
Bone -implant Implant -percutaneous part
Percutaneous part
- soft tissue
OPRA Ti6Al4 V Thread Press-fit and locking screw Polished
ILP cobalt-chrome-
molybdenum
Press-fit Press-fit and locking screw Polished
OPL Ti6Al4 V Press-fit Press-fit and locking screw Polished
ITAP Ti6Al4 V Press-fit – Perforated flange/polished
POP Ti6Al4 V Press-fit Press-fit and locking screw Ceramic coating
Compress Ti6Al4 V Transverse pins/
axial compression
Taper connection Porous titanium/polished
Keep walking advanced Ti6Al4 V Press-fit Press-fit and locking screw Polished
AEAHBM Ti6Al4 V Thread/press-fit – Porous tantalum
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serving as a collar towards the distal end of the bone.
In the redesigned system, the tapered thread was ex-
changed for an unthreaded stem with longitudinal
splines in order to provide more rotational stability.
Number of Treated Human Subjects
There is only limited information in peer-reviewed
publications regarding the number of patients who
have been recipients of implant systems for bone-an-
chored limb prostheses. It has been reported that
approximately 150 patients were treated with the
OPRA system in Sweden between 1990 and 200934;
approximately 150 patients had been treated with the
ILP system in Germany, the Netherlands, and Aus-
tralia until 20163; and at least 22 patients were treated
with the OPL system in Australia between November
2013 and December 2014.6 Since those reports, more
patients have been treated with each of these systems.
Oral and unveriﬁed online reports indicate that the
current number of patients treated with each of the
clinically available systems is in the hundreds; how-
ever, the actual numbers must be veriﬁed in formally
reported clinical studies. For the other systems, the
number of treated patients are lower. The peer-re-
viewed literature has only reported a single subject
treated with the ITAP system,50 11 subjects treated
with the COMPRESS system,57 and a single subject
treated with the keep walking advanced27 system.
According to oral and unveriﬁed online reports, a
further 20 transfemoral patients have been treated with
the ITAP system in the clinical trial, and at least eight
people have been treated with the POP system in the
early feasibility study.
Surgical Approach
Of the systems implanted in human subjects, ITAP
is the only system that is always implanted in a single
surgery. The other systems have mostly followed two-
stage surgical protocols, although single-stage proce-
dures have been reported for the OPRA, the OPL and
the COMPRESS systems.7,56,57 In the ﬁrst stage, an
incision is made in the distal end of the stump, the
residual bone is reamed and prepared for insertion of
the implant, and the implant is then inserted and the
skin is closed. The bone and the skin are allowed to
heal for a period of time to enable osseointegration
between the bone and the implant. In the second stage,
the percutaneous part is inserted with its proximal end
into the implanted component and the distal end
extending through the skin.
Rehabilitation
Diﬀerent healing and rehabilitation times are used
before the implant can be fully loaded. A schedule is
followed in which progressively higher loads are
applied to the external part of the implant system until
full loading with the external prosthesis is eventually
allowed.8,30,48,50 It is important to have a close col-
laboration between the physiotherapist and prosthetist
to monitor the rehabilitation of the patient and to
ensure that the prosthetic components are carefully
selected and aligned. It is recommended that a pros-
thetic knee component providing effortless ﬂexion and
controlled extension is used before full weight-bearing
is allowed.30
The recommended period between the ﬁrst surgery
and the time when the patient is able/allowed to fully
load the system with an external prosthesis varies
among individuals, implant systems, and amputation
level. According to the standard OPRA protocol, this
period should be approximately 12 months for trans-
femoral amputees,30,56 while for the ILP and the OPL,
full weight bearing on the prosthesis is recommended
after 2.5–3 and 4–5 months, respectively.8,10,49 For the
other systems, the number of cases reported in this
regard is too small.
Bone-implant Interface
In order to have a long-term successful outcome, it
is essential to obtain a stable connection between the
implant and the bone. It is believed that small relative
movements between the implant and the bone can
cause the formation of a ﬁbrous layer around the im-
plant, leading to mechanical instability and the need
for implant revision. Diﬀerent approaches have been
used to achieve a stable connection between the im-
plant and the bone. Osseointegration is often cited as
the underlying working mechanism, but limited evi-
dence has been provided in this regard. Veriﬁcation of
achieved osseointegration would preferably include X-
ray analysis and radiostereometric analysis (RSA),60 as
well as high-resolution interface analysis after implant
retrieval.64 The only system that has provided such
evidence in peer-reviewed literature is the OPRA im-
plant system.60,64
Three diﬀerent anchoring strategies were found in
the studied systems: (1) a threaded connection, which is
utilised in the OPRA and the original AEAHBM sys-
tem; (2) a press-ﬁt interface, which is present in the
ILP, OPL, ITAP, POP, Keep Walking Advanced, and
the redesigned AEAHBM system; and (3) a bone an-
chor with transverse intraosseous pins in combination
with a compressive force and bone-ingrowth at the
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bone-collar interface, as is used in the COMPRESS
system. A threaded connection inherently has good
mechanical stability in the longitudinal direction. Ini-
tial rotational stability is achieved by friction and long-
term stability is achieved by a combination of friction
and mechanical interlocking, where the bone tissue
grows into macro, micro, and nano ‘‘irregularities’’ on
the implant surface. The press-ﬁt interface has a lower
longitudinal axial stability, initially relying solely on
friction and in the long term relying on both friction
and bone ingrowth for longitudinal and rotational
stability. A bone anchor with transverse intraosseous
pins, in combination with a compressive bone collar
with bone ingrowth promoting surface properties,
naturally creates a high mechanical stability, both in
the longitudinal and the rotational directions. In order
to create a more stable interface between the implant
and the bone, additional features have been added to
some of these systems. These include longitudinal
splines or ﬂuted regions for improved rotational sta-
bility as in OPRA, OPL, ITAP, POP, Keep Walking
Advanced and the AEAHBM systems; a curvature
along the longitudinal axis, as is utilized in the ILP and
the OPL systems; and a ﬂared, or collared interface at
the distal bone interface, as used in all systems except
OPRA. Geometrical ﬁt between the implant and the
bone appears to be crucial for a successful outcome as
observed by loosening and failure of undersized
implants,5,8 or fracture at the insertion of oversized
implants.44 Bone ingrowth is dependent on the implant
material, the implant design, and the geometrical ﬁt in
the bone.9 In all of the studied implant systems except
the ILP, the bulk material of the implant is the tita-
nium alloy Ti6Al4 V. In the ILP, a cobalt-chrome-
molybdenum alloy is used instead. Porous exterior
surfaces are used locally in all implant systems to en-
hance the bone ingrowth. The OPRA system has the
laser-induced nanoporous microstructure BioHelixTM
surface, the ILP system has a macroporous spongiosa
surface, and the OPL has a rough surface of plasma
sprayed titanium on the distal half of the implant.
Similarly, the distal region of the POP implant,
including a collar at the interface toward the distal end
of the bone, is covered by a porous layer of pure
titanium. The COMPRESS system utilises a hydrox-
yapatite porous collar in combination with a com-
pressive force of 1.8-3.6 kN57,65 across the interface,
while the AEAHBM has a collar of porous tantalum
toward the distal bone end. In the Keep Walking
Advanced system, small holes are located on the
proximal end of the UHMWPE (ultra-high-molecular-
weight polyethylene) spacer at the interface toward the
distal end of the bone.26 The ITAP has a coating of
hydroxyapatite on the distal part of the intramedullary
portion of the implant.
Implant-percutaneous Part Interface
In the OPRA system, the abutment is connected to
the ﬁxture by a smooth surface press-ﬁt. The abutment
is also clamped to the ﬁxture by a preload from the
abutment screw with a thread engagement with the
ﬁxture proximal to the abutment.
The ILP and OPL systems have a press-ﬁt Morse
taper connection between the implant and the percu-
taneous part, called the dual-cone adapter. A safety
screw inserted longitudinally from the dual-cone
adapter to the implant provides additional locking of
the components.
In the POP system used in the ongoing human trial,
the implant is connected to the exterior of the body by
a ceramic-coated percutaneous post, which is clamped
to the implant with a locking screw.12
The porous coated collar in the COMPRESS system
is connected to the bone anchor by a traction rod and a
compression nut, which, in combination with a num-
ber of Belleville washers, apply a compressive force at
the distal bone end.
In the Keep Walking Advanced system, the implant
is attached to the percutaneous extension by a tapered
interface and a locking screw, which has a proximal
thread engagement with the implant.26
Percutaneous Interface
The percutaneous component of the OPRA system
is the abutment, which has a smooth polished surface
to minimise contact and friction at the skin interface.
In the ILP and the OPL systems, the percutaneous
interface consists of the dual-cone adapter and, in
some designs, also the distal end of the implant. The
percutaneous surfaces of the implant are smooth-pol-
ished and have a niobium-oxide coating aimed to
minimise soft tissue adhesion at the percutaneous
interface.5,23
In the ITAP system, the percutaneous interface is
stabilised by the subdermal porous ﬂange, allowing for
soft tissue ingrowth and suture of the thinned skin ﬂap
to minimise relative movement.50 Distal to the porous
ﬂange, the peg for attachment of the external pros-
thesis is coated with a low-friction DLC (diamond-like
carbon) surface coating to reduce bacterial adhe-
sion.22,50,66
The COMPRESS and the AEAHBM systems both
have a porous subdermal surface distal to the bone to
promote soft tissue integration and to provide a soft
tissue seal to the implant. In the COMPRESS system,
the porous coating consists of titanium, while the
AEAHBM system uses tantalum.13,18,57 The percuta-
neous interface of the POP and the COMPRESS sys-
tems are characterised by smooth low-friction surfaces,
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similar to the other implant systems for human
implantation.
Safety Devices
Safety precautions have been taken to protect the
bone and the implant from direct exposure to high
loads, especially in the event of a fall. The OPRA
implant system has diﬀerent safety devices for diﬀerent
amputation levels. They are separate components,
which are connected between the abutment and the
external prosthesis and automatically release the con-
nection between the implant and the prosthesis if they
are exposed to a load exceeding a pre-set limit. All
OPRA safety systems protect against excessive torque
around the longitudinal axis, while the transfemoral
system also protects from excessive bending moments
in the normal plane of the longitudinal axis. Release
limits for the systems are set to be high enough to
avoid release during normal use, but low enough to
ensure that the bone or the implant system is not
damaged. The limits are set to 15 Nm torque and
70 Nm bending moment. In case of release, the safety
system can be restored to normal operation by the
patient without the need to meet a prosthetist. The ILP
and OPL safety systems are protecting from high tor-
ques being transferred to the implant by a connection
adapter25 or a click safety adapter23,77 attached
between the distal end of the dual-cone adapter and the
external prosthesis. The connection adapter is equip-
ped with a safety mechanism, consisting of one or
several shear pins, designed to break in case the im-
plant is exposed to high torsional loads.11 If this hap-
pens, replacement of the broken part can be done in a
clinical setting.3 There is limited information about the
safety systems for the other implant systems. However,
the case report about the transhumeral ITAP patient
mentions that the ITAP is equipped with a safety
component, mounted between the implant and the
prosthesis, which is designed to break at loads corre-
sponding to 10 kg or more.50
DISCUSSION
Several systems have been developed for bone-an-
chored limb prostheses and diﬀerent approaches have
been employed to achieve a stable attachment between
the implant and the bone. Comparing the ILP and
OPL implant systems with the OPRA implant system
reveals that the latter follows a slower rehabilitation
protocol for lower limb amputations. This could
indicate that a longer time is needed to achieve a
mechanically stable interface for a threaded implant
than for a press-ﬁt implant. However, the historical
development of the implants must also be considered.
The threaded implant design used in the OPRA system
was developed using experience gained from the dental
industry as the ﬁrst and longest user of osseointegra-
tion, whereas the press-ﬁt implant design originates
from intramedullary hip implants, which have a tra-
dition of ﬁxation to the bone by press-ﬁt in combina-
tion with bone cement.
The OPRA system follows a conservative approach,
with a healing period before any load is applied to the
implant. This is based on experimental results from
animal studies, which have shown that the mechanical
capacity of the bone-implant interface for threaded
implants is improved by healing under unloaded con-
ditions in both torsion and pull-out load.17,47 For the
pioneers in the ﬁeld of bone-anchored limb prostheses,
the highest priority during the development has been to
achieve a successful end result, rather than rehabilita-
tion speed. The primary stability is determined by the
geometrical ﬁt between the implant and the bone, the
bone quality and quantity, and thus varies between
individuals. If the primary stability of the implant after
the surgery is sufﬁcient to withstand initial loading, the
rehabilitation could start earlier and signiﬁcantly re-
duce the total recovery time. On the other hand, if the
primary stability is insufﬁcient, the reduced weakness
of the bone-implant interface during the initial healing
would potentially lead to a higher incidence of early
ﬁxture loosening if such a reduced healing time pro-
tocol was adopted.
Another diﬀerence between the clinically available
implant systems is the intramedullary length of the
implant (140–180 mm for ILP, 160 mm for OPL, and
80 mm for OPRA). This indicates that press-ﬁt im-
plants require a longer intramedullary length to
achieve a stable connection in the longitudinal direc-
tion than a threaded implant. A shorter implant length
is advantageous, as it imposes fewer eligibility con-
straints on the residual stump length. Furthermore, in
the event of a catastrophic failure, with the worst-case
scenario requiring re-amputation above the implant, a
shorter intramedullary length leads to a longer residual
length of the stump after the re-amputation surgery.
To achieve bone ingrowth, the trend is to use the
titanium alloy Ti6Al4 V as the bulk material in com-
bination with porous surface on the implant. The de-
gree of porosity varies between systems, but inevitably
comes with a trade-oﬀ by having reduced mechanical
strength and fatigue properties in these regions. Most
of the systems used in humans are modular, which
limits the mechanical capacity but simpliﬁes the sur-
gical intervention in case a revision surgery is needed.
To avoid irritation and superﬁcial infections, which
could potentially lead to more severe deep infections,
two approaches are employed at the percutaneous
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interface in the diﬀerent implant systems. The ﬁrst
approach is to try to prevent skin and soft tissue
adhesion by having a polished surface on the percu-
taneous component as in the OPRA, OPL, POP, Keep
Walking Advanced and later designs of the ILP sys-
tem. In the OPRA system, this approach is combined
with suture of the skin directly to the distal end of the
bone at the percutaneous interface in order to mini-
mize relative movement and to create an infection
barrier. The other approach is to create an infection
barrier by promoting soft-tissue ingrowth to the per-
cutaneous component. This approach is used in the
ITAP, COMPRESS, AEAHBM, and earlier designs of
the ILP systems, by having a porous surface on the
percutaneous component.
The scientiﬁc literature contains limited information
about the mechanical features of bone-anchoring im-
plant systems. Reporting the performance of such
systems under mechanical stress in bench tests, or
activities of the daily living, has been given a low pri-
ority by the development teams in favor of clinical
outcomes. The available literature refers to osseointe-
gration as the responsible mechanism that allows direct
skeletal attachment of limb prostheses; however,
insuﬃcient evidence has been provided for most of the
implant systems on the degree of osseointegration
achieved with the diﬀerent designs.
It is diﬃcult to compare the available systems be-
cause they have undergone several changes over time,
and clinical trials continue to be limited. The three
design principles known at present are fundamentally
diﬀerent and pose particular advantages and disad-
vantages, which might in the future serve as the basis
to determine which approach is most suitable for
particular subjects.
CONCLUSION
Current systems for bone anchoring of limp pros-
theses use intramedullary implants. Primary stability
between bone and implant is achieved by one of three
strategies: a threaded connection, a press-ﬁt connec-
tion, or axial compression. Secondary stability is
achieved by bone ingrowth into porous surfaces of the
implant. Although there are large diﬀerences between
current implant systems, the three clinically available
systems (OPRA, ILP, and OPL) have shown func-
tional improvements for patients with socket-related
issues. Recent developments of implant systems, sur-
gical protocols, and safety devices have reduced the
rate of mechanical failure and infectious complica-
tions. Moreover, further improvements are likely to
continue based on ﬁeld data and information from the
ongoing human trials. Future developments are likely
to address several factors, such as the perceived long
rehabilitation time before loading, the need for two
separate surgeries, the incidence of superﬁcial infection
at the percutaneous interface, mechanical failures in
highly demanding activities, and the possibility of
additionally providing closed-loop, neuro-muscular
control of the limb prostheses.
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